Ozlem Equils

811 total citations · 1 hit paper
11 papers, 548 citations indexed

About

Ozlem Equils is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Ozlem Equils has authored 11 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Ozlem Equils's work include Antifungal resistance and susceptibility (3 papers), Reproductive System and Pregnancy (2 papers) and Vitamin D Research Studies (2 papers). Ozlem Equils is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Reproductive System and Pregnancy (2 papers) and Vitamin D Research Studies (2 papers). Ozlem Equils collaborates with scholars based in United States, United Kingdom and Australia. Ozlem Equils's co-authors include Katherine Kricorian, Rachel Civen, Martin Hewison, Amber Kaplan, Lisa Nguyen, Yasemin Bulut, Bruce W. Hollis, Carol L. Wagner, Venu Lagishetty and Nancy Q. Liu and has published in prestigious journals such as PLoS ONE, Endocrinology and Biology of Reproduction.

In The Last Decade

Ozlem Equils

9 papers receiving 535 citations

Hit Papers

COVID-19 vaccine hesitancy: misinformation and perception... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ozlem Equils United States 8 228 149 138 129 109 11 548
Jill Diesel United States 9 89 0.4× 78 0.5× 85 0.6× 18 0.1× 179 1.6× 13 406
Fadia Dib France 10 263 1.2× 78 0.5× 7 0.1× 94 0.7× 39 0.4× 26 497
Marelign Tilahun Malaju Ethiopia 11 88 0.4× 145 1.0× 11 0.1× 42 0.3× 43 0.4× 23 444
Carolina Batista Switzerland 12 180 0.8× 211 1.4× 4 0.0× 63 0.5× 35 0.3× 29 543
Paul Scanlon United States 9 126 0.6× 80 0.5× 14 0.1× 46 0.4× 27 0.2× 28 376
Joshua Nazareth United Kingdom 8 114 0.5× 240 1.6× 7 0.1× 36 0.3× 49 0.4× 24 607
Atefeh Vaezi Iran 11 29 0.1× 70 0.5× 16 0.1× 21 0.2× 43 0.4× 40 358
Sharon Bond United States 14 34 0.1× 39 0.3× 19 0.1× 41 0.3× 61 0.6× 44 527
Tadao Ooka Japan 11 67 0.3× 49 0.3× 7 0.1× 43 0.3× 47 0.4× 58 384
Anokhi Ali Khan United Kingdom 6 120 0.5× 67 0.4× 5 0.0× 17 0.1× 69 0.6× 10 372

Countries citing papers authored by Ozlem Equils

Since Specialization
Citations

This map shows the geographic impact of Ozlem Equils's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ozlem Equils with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ozlem Equils more than expected).

Fields of papers citing papers by Ozlem Equils

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ozlem Equils. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ozlem Equils. The network helps show where Ozlem Equils may publish in the future.

Co-authorship network of co-authors of Ozlem Equils

This figure shows the co-authorship network connecting the top 25 collaborators of Ozlem Equils. A scholar is included among the top collaborators of Ozlem Equils based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ozlem Equils. Ozlem Equils is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Equils, Ozlem, Shawn Flanagan, Johan Vingerhoets, et al.. (2025). 573. CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model. Open Forum Infectious Diseases. 12(Supplement_1).
3.
Kricorian, Katherine, Rachel Civen, & Ozlem Equils. (2021). COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Human Vaccines & Immunotherapeutics. 18(1). 1950504–1950504. 262 indexed citations breakdown →
4.
Equils, Ozlem, et al.. (2019). 2531. Using Peer-to-Peer Education to Increase Awareness and Uptake of HPV Vaccine Among Chinese International Students. Open Forum Infectious Diseases. 6(Supplement_2). S879–S880. 2 indexed citations
5.
Equils, Ozlem, et al.. (2018). Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines. Human Vaccines & Immunotherapeutics. 15(3). 637–642. 10 indexed citations
7.
McLaughlin, John M., Ozlem Equils, Jalal A. Aram, et al.. (2013). Risk‐adjusted relationship between voriconazole utilization and non‐melanoma skin cancer among lung and heart/lung transplant patients. Transplant Infectious Disease. 15(4). 329–343. 25 indexed citations
8.
Liu, Nancy Q., Yi Ouyang, Yasemin Bulut, et al.. (2013). Dietary Vitamin D Restriction in Pregnant Female Mice Is Associated With Maternal Hypertension and Altered Placental and Fetal Development. Endocrinology. 154(7). 2270–2280. 59 indexed citations
9.
Diep, Binh An, Ozlem Equils, David B. Huang, & Ron P. Gladue. (2012). Linezolid Effects on Bacterial Toxin Production and Host Immune Response: Review of the Evidence. Current Therapeutic Research. 73(3). 86–102. 22 indexed citations
10.
Equils, Ozlem, et al.. (2010). A Computer Simulation of Progesterone and Cox2 Inhibitor Treatment for Preterm Labor. PLoS ONE. 5(1). e8502–e8502. 15 indexed citations
11.
Kaplan, Amber, et al.. (2008). Vitamin D Induces Innate Antibacterial Responses in Human Trophoblasts via an Intracrine Pathway1. Biology of Reproduction. 80(3). 398–406. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026